NCT06418399View on ClinicalTrials.gov

The Role of Central Sensitization in Pain, Functionality, and Quality of Life in Cancer Patients

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions

Central Sensitization

Interventions

OTHER

cancer patients

Patients aged between 18 and 80 years with cancer-related pain lasting for more than 3 months will be included.

Sponsors

Lead Sponsor

Marmara University

All Listed Sponsors

lead

Marmara University

OTHER

NCT06418399 - The Role of Central Sensitization in Pain, Functionality, and Quality of Life in Cancer Patients | Biotech Hunter | Biotech Hunter